CLEARSIDE BIOMEDICAL INC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About CLSD
Clearside Biomedical, Inc. is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space (SCS). The Company's SCS injection platform, utilizing its patented SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. The Company is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company's lead program, CLS-AX (axitinib injectable suspension), for the treatment of neovascular age-related macular degeneration (wet AMD). It developed and gained approval for its product, XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the United States through a commercial partner.
Find out what a historical investment in CLEARSIDE BIOMEDICAL INC would be worth today using our CLSD stock calculator.
$66.34M
-
0.00%
266.97K
$0.93
$0.82
$0.87
$1.65
$0.70
Ready to start your investing journey with Stake?
Open an accountCLSD FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CLSD
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CLSD
on Stake
Buy CLSD from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of CLSD from only US$10 with fractional shares
